Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRC-002 in Complex Regional Pain Syndrome
NCT06393101Phase 1Recruiting
- Sponsor
- University of California, San Diego
- Start
- Jun 2024
- Primary completion
- Jun 2029
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BRC-002 in complex regional pain syndrome (CRPS) (2 arms), sponsored by University of California, San Diego. Primary endpoint: Change in complex regional pain syndrome pain and heat pain measured with VAS. Started Jun 2024; status: recruiting.
02
Drugs
BRC-002
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT06393101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06393101.